温阳消癥方调控TFEB介导的自噬流稳态缓解腺嘌呤诱导的肾间质纤维化OA
Wenyang Xiaozheng Decoction Alleviates Adenine-Induced Renal Interstitial Fibrosis by Regulating TFEB-Mediated Autopha-gic Flux Homeostasis
[目的]探讨温阳消癥方对腺嘌呤诱导的慢性肾功能衰竭(chronic renal failure,CRF)相关肾间质纤维化(renal interstitial fibrosis,RIF)的作用及分子机制.[方法]60只雄性SD大鼠随机分为空白对照组、模型组、温阳消癥方组、自噬抑制剂3-甲基腺嘌呤(3-methyladenine,3-MA)组、自噬诱导剂雷帕霉素(rapamycin)组、自噬诱导剂海藻糖(trehalose)组,每组10只.除空白对照组外,其余各组采用250 mg/(kg·d)腺嘌呤混悬液灌胃4周,构建RIF模型.建模成功后,空白对照组与模型组予20 mL·kg-1蒸馏水灌胃,每日1次;温阳消癥方组予2.4 g·mL-1生药水煎液灌胃,每日1次;3-MA组予15 mg·kg-1的3-MA溶液腹腔注射,隔日1次;雷帕霉素组予1.5 mg·kg-1的雷帕霉素溶液灌胃,每日1次;海藻糖组予5%海藻糖溶液20 mL·kg-1灌胃,每日1次,各组均干预4周.建模后(第4周末)及干预后(第8周末),检测Scr、BUN、24 h尿蛋白水平及肾组织活性氧(reactive oxygen species,ROS)含量;采用Real-time PCR检测肾组织微管相关蛋白1轻链3-Ⅱ(microtubule-associated protein 1 light chain 3-Ⅱ,LC3-Ⅱ)、自噬相关基因Beclin-1、自噬底物蛋白p62、哺乳动物雷帕霉素靶蛋白(mammalian target of rapamycin,mTOR)、转录因子EB(transcription factor EB,TFEB)的mRNA表达;免疫印迹法检测上述基因对应蛋白表达;HE染色及Masson染色观察肾组织病理形态,并量化纤维化程度.[结果]与空白对照组比较,模型组大鼠出现多饮多尿、食欲下降等症状,体质量显著降低(P<0.01),Scr、BUN、24 h尿蛋白水平及肾脏组织ROS含量显著升高(P<0.01);肾组织LC3-Ⅱ、Beclin-1的mRNA及蛋白表达显著上调(P<0.05,P<0.01),p62、mTOR蛋白表达显著下调(P<0.05);肾组织病理损伤严重,胶原纤维大量沉积,纤维化程度显著加重.与模型组比较,干预4周后温阳消癥方组大鼠体质量显著增加(P<0.01),温阳消癥方组及3-MA组Scr、BUN、24 h尿蛋白水平及肾脏组织ROS含量显著降低(P<0.01,P<0.05);上述两组肾组织LC3-Ⅱ、Beclin-1 mRNA及蛋白表达显著下调(P<0.01,P<0.05),p62 mRNA及蛋白表达显著上调(P<0.01,P<0.05);3-MA组TFEB的mRNA表达显著降低(P<0.05);肾脏组织病理损伤明显减轻,胶原纤维沉积显著减少,纤维化程度显著改善.雷帕霉素组、海藻糖组上述生化指标、自噬及TFEB相关指标无显著改善,其中雷帕霉素组24 h尿蛋白水平、LC3-Ⅱ及Beclin-1表达进一步升高,海藻糖组TFEB表达较模型组升高,两组病理损伤及纤维化程度无明显缓解.组间进一步比较,温阳消癥方组与3-MA组间各项指标比较差异均无统计学意义(P>0.05),且两组上述指标均优于雷帕霉素组、海藻糖组(P<0.05,P<0.01).[结论]温阳消癥方可通过调控TFEB表达,平衡自噬流稳态,抑制氧化应激水平,进而缓解腺嘌呤诱导的RIF,其机制与调控TFEB介导的自噬通路密切相关.
[Objective]To investigate the effect of Wenyang Xiaozheng Decoction on adenine-induced renal interstitial fibrosis(RIF)associated with chronic renal failure(CRF),and clarify its molecular mechanism.[Methods]Sixty male SD rats were randomly divided into blank control group,model group,Wenyang Xiaozheng Decoction group,autophagy inhibitor 3-methyladenine(3-MA)group,autophagy inducer rapamycin group and autophagy inducer trehalose group,with 10 rats in each group.Except for blank control group,the other groups were given 250 mg/(kg·d)adenine suspension by gavage for 4 weeks to establish the RIF model.After successful modeling,blank control group and model group were given 20 mL·kg-1 distilled water by gavage,once a day;Wenyang Xiaozheng Decoction group was given 2.4 g·mL-1 Wenyang Xiaozheng Decoction by gavage,once a day;3-MA group was given 15 mg·kg-1 3-MA intraperitoneal injection,once every other day;rapamycin group was given 1.5 mg·kg-1 rapamycin diluted with 0.9%sodium chloride injection by gavage,once a day;trehalose group was given 5%trehalose solution 20 mL·kg-1 by gavage,once a day,all groups were intervened for 4 weeks.At the end of 4th week(post-modeling)and 8th week(post-intervention),Scr,BUN,24-hour urinary protein levels and renal reactive oxygen species(ROS)content were detected.Real-time PCR was used to detect the mRNA expressions of microtubule-associated protein 1 light chain 3-Ⅱ(LC3-Ⅱ),Beclin-1,p62,mammalian target of rapamycin(mTOR)and transcription factor EB(TFEB)in renal tissues.Western blot was used to detect the protein expressions of the above genes.HE staining and Masson staining were used to observe renal pathological morphology and quantify the degree of fibrosis.[Results]Compared with blank control group,the model group showed symptoms such as polydipsia,polyuria,decreased appetite and listlessness,with significant weight loss(P<0.01),significantly increased Scr,BUN,24-hour urinary protein and renal ROS content(P<0.01);the mRNA and protein expressions of LC3-Ⅱ,Beclin-1 in renal tissues were significantly up-regulated(P<0.05,P<0.01),while the protein expressions of p62 and mTOR were significantly down-regulated(P<0.05);severe renal pathological damage,massive collagen fiber deposition and significantly aggravated fibrosis were observed.Compared with model group,after 4 weeks,Wenyang Xiaozheng Decoction group showed significantly increased body weight(P<0.01).Both the Wenyang Xiaozheng Decoction and 3-MA groups demonstrated significantly decreased levels of Scr,BUN,24-hour urinary protein and renal ROS content(P<0.01,P<0.05).Concurrently,both treatments significantly down-regulated LC3-Ⅱ and Beclin-1 expression at both mRNA and protein levels(P<0.01,P<0.05),while significantly up-regulating p62 mRNA and protein expression(P<0.01,P<0.05).Additionally,TFEB mRNA expression was significantly reduced in 3-MA group(P<0.05);renal pathological damage was alleviated,collagen fiber deposition was reduced,and fibrosis was significantly alleviated.Compared with model group,there was no significant improvement in the above biochemical indicators,autophagy and TFEB-related indicators in rapamycin group and trehalose groups;among them,the 24 hour urinary protein level,LC3-Ⅱ and Beclin-1 expressions in rapamycin group were even further increased,only TFEB expression in trehalose group was significantly increased,and the pathological damage and fibrosis degree in both groups were not significantly relieved.No significant differences were found in all indicators between Wenyang Xiaozheng Decoction group and 3-MA group(P>0.05),and both were superior to rapamycin group and trehalose group(P<0.05,P<0.01).[Conclusion]Wenyang Xiaozheng Decoction alleviates adenine-induced RIF through TFEB-dependent restoration of autophagic flux and suppression of oxidative stress,implicating the TFEB-mediated autophagic pathway as a critical therapeutic target.
魏升;钟光辉;曹晓丹;张荣荣;毛青云
浙江中医药大学附属宁波市中医院 浙江,宁波 315010浙江中医药大学附属宁波市中医院 浙江,宁波 315010浙江中医药大学附属宁波市中医院 浙江,宁波 315010浙江中医药大学附属宁波市中医院 浙江,宁波 315010浙江中医药大学附属宁波市中医院 浙江,宁波 315010
医药卫生
温阳消癥方肾间质纤维化慢性肾功能衰竭自噬TFEB氧化应激信号通路中药复方
Wenyang Xiaozheng Decoctionrenal interstitial fibrosischronic renal failureautophagyTFEBoxidative stresssignaling pathwaytraditional Chinese medicine compound
《浙江中医药大学学报》 2026 (3)
267-277,11
国家自然科学基金项目(82205063)浙江省自然科学基金项目(HDMY24H270004)浙江省中医药科技计划项目(2021ZB251)宁波市科技计划项目(2022J284) National Natural Science Foundation Project(82205063)Zhejiang Natural Science Foundation Project(HDMY24H270004)Zhejiang Traditional Chinese Medicine Science and Technology Project(2021ZB251)Ningbo Science and Technology Project(2022J284)
评论